<DOC>
	<DOC>NCT00245921</DOC>
	<brief_summary>To evaluate the safety and contraceptive efficacy of an oral contraceptive containing a combination of LNG 90 mg/EE 20 mg in a continuous-use regimen.</brief_summary>
	<brief_title>Study Evaluating Levonorgestrel and Ethinyl Estradiol for Oral Contraception</brief_title>
	<detailed_description />
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Levonorgestrel</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Ethinyl estradiol, levonorgestrel drug combination</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>Healthy women aged 18 to 49 years Regular (21 to 35 day) menstrual cycles for the 3month period preceding visit 1 Must be sexually active and at risk for becoming pregnant. Planned use of any other form of birth control other than the test article. Depression requiring hospitalization or associated with suicidal ideation within the last 3 years. High blood pressure (defined as elevated sitting blood pressure: &gt; 140/90 mm Hg).</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>May 2006</verification_date>
	<keyword>contraception</keyword>
</DOC>